Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)

• Status: Terminated
• Trial end date: 2015-01-01

Summary

Randomised trial comparing standard chemotherapy with carboplatin and etoposide with a combination of topotecan and cisplatin in patients with inoperable lung cancer of small cell type.

• Phase: Phase 3

Details

• Lead Sponsor: Danish Oncological Lung Cancer Group
• Treatments: Carboplatin; Cisplatin; Etoposide; Etoposide phosphate; Topotecan